- Home
- AIRE vs EPIX Comparison
AIRE vs EPIX Comparison
Compare AIRE & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRE
- EPIX
- Stock Information
- Founded
- AIRE 2021
- EPIX 2009
- Country
- AIRE United States
- EPIX Canada
- Employees
- AIRE N/A
- EPIX N/A
- Industry
- AIRE
- EPIX Biotechnology: Pharmaceutical Preparations
- Sector
- AIRE
- EPIX Health Care
- Exchange
- AIRE Nasdaq
- EPIX Nasdaq
- Market Cap
- AIRE 86.1M
- EPIX 76.8M
- IPO Year
- AIRE N/A
- EPIX N/A
- Fundamental
- Price
- AIRE $1.84
- EPIX $1.72
- Analyst Decision
- AIRE Strong Buy
- EPIX Hold
- Analyst Count
- AIRE 1
- EPIX 3
- Target Price
- AIRE $3.00
- EPIX $2.00
- AVG Volume (30 Days)
- AIRE 288.5K
- EPIX 252.4K
- Earning Date
- AIRE 03-23-2025
- EPIX 02-11-2025
- Dividend Yield
- AIRE N/A
- EPIX N/A
- EPS Growth
- AIRE N/A
- EPIX N/A
- EPS
- AIRE N/A
- EPIX N/A
- Revenue
- AIRE $379,241.00
- EPIX N/A
- Revenue This Year
- AIRE $514.68
- EPIX N/A
- Revenue Next Year
- AIRE $129.41
- EPIX N/A
- P/E Ratio
- AIRE N/A
- EPIX N/A
- Revenue Growth
- AIRE 18.11
- EPIX N/A
- 52 Week Low
- AIRE $0.53
- EPIX $1.40
- 52 Week High
- AIRE $4.49
- EPIX $9.92
- Technical
- Relative Strength Index (RSI)
- AIRE 53.08
- EPIX 47.93
- Support Level
- AIRE $1.70
- EPIX $1.69
- Resistance Level
- AIRE $1.93
- EPIX $1.83
- Average True Range (ATR)
- AIRE 0.13
- EPIX 0.07
- MACD
- AIRE 0.02
- EPIX 0.01
- Stochastic Oscillator
- AIRE 68.42
- EPIX 57.69
About AIRE reAlpha Tech Corp.
ReAlpha Tech Corp is a real estate technology company that develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability; and has an app for investment into the properties that it purchased aimed at retail investors. The company's reportable segments are; Platform Services, which derives key revenue, and the Rental business segment.
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.